CIK 0001740279
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
IN8BIO, INC.
Sign in to watch- Ticker
- INAB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 825462585
- Phone
- +1 646-600-6438
- Business address
- EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, NEW YORK, NY, 10118
- Former names
- Incysus Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-19 | Whitfill Travis Director | Grant or award · Stock Option (right to buy) | +42,676 | 42,676 | ||
| 2024-06-12 | Whitfill Travis Director | Grant or award · Stock Option (right to buy) | +33,650 | 33,650 | ||
| 2023-06-15 | Whitfill Travis Director | Grant or award · Stock Option (right to buy) | +85,000 | 85,000 | ||
| 2022-06-01 | Whitfill Travis Director | Grant or award · Stock Option (right to buy) | +13,500 | 13,500 | ||
| 2022-06-01 | Whitfill Travis Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2021-07-29 | Whitfill Travis Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 |
Page 1 of 1 · 6 trades